Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Cancer Genetics|April 29, 2017
Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samplesMeenakshi Mehrotra, Rajyalakshmi Luthra, Ronald Abraham, et al.
The Journal of Molecular Diagnostics : JMD|December 27, 2016
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid TumorsRajyalakshmi Luthra, Keyur P Patel, Mark J Routbort, et al.
Discovery Medicine|February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gapsAnn M Bailey, Yong Mao, Jia Zeng, et al.
Cancer|September 2, 2011
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphomaPei Lin, Timothy J Dickason, Luis E Fayad, et al.
Cytometry. Part B, Clinical Cytometry|July 16, 2020
Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cellsKirill A Lyapichev, Ismael Bah, Auris Huen, et al.
Haematologica|June 30, 2017
Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutationRashmi Kanagal-Shamanna, Sanam Loghavi, Courtney D DiNardo, et al.
Annals of Diagnostic Pathology|April 5, 2016
Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 casesLe Le Aye, Sanam Loghavi, Ken H Young, et al.
American Journal of Clinical Pathology|April 25, 2022
Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal CarcinomaMichael P Zaleski, Hui Chen, Sinchita Roy-Chowdhuri, et al.
American Journal of Clinical Pathology|March 13, 2014
Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencingBryce P Portier, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, et al.
Plos One|September 18, 2018
Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS eraSantiago Montes-Moreno, Mark J Routbort, Elijah J Lohman, et al.
Pageof 12